The epidermal growth factor (EGF) receptor is activated by both EGF and transforming growth factor-alpha (TGF-a). Using immunohistochemical and immunoblotting techniques we now report that the EGF receptor, EGF, and TGF-a are found in both pancreatic acini and ducts in the normal human pancreas, and that all three proteins are expressed at higher levels in human pancreatic cancer tissues. Using in situ hybridization techniques, we also report that the mRNA encoding the EGF receptor, EGF, and TGF-a colocalize with their respective proteins. Northern blot analysis of total RNA indicates that, by comparison with the normal pancreas, the pancreatic tumors exhibit a 3-, 15-, and 10-fold increase in the mRNA levels encoding the EGF receptor, EGF, and TGF-a, respectively. Furthermore, by in situ hybridization, there is a marked increase in these mRNA moieties within the tumor mass. These findings suggest that EGF and TGF-a may participate in the regulation of normal pancreatic exocrine function, and that overexpression of the EGF receptor and its two principal ligands may contribute to the pathophysiological processes that occur in human pancreatic cancer. (J. Clin. Invest. 1992Invest. . 90:1352Invest. -1360
Introduction
Carcinoma ofthe pancreas is the fourth or fifth leading cause of cancer death in the United States (1) . The one-year overall survival rate in patients with pancreatic carcinoma is only 12%, and more than 98% of the patients are dead within five years (2) . The diagnosis of pancreatic cancer is frequently established at an advanced stage, which precludes the patients from having surgery. Moreover, during surgical exploration of patients who ostensibly have localized disease, as many as 50% of the pancreatic carcinomas are found to have already spread locally or regionally (3) . Nonsurgical treatment modalities for pancreatic cancer have not been successful, partly because of the tumor's propensity to metastasize and the intrinsic resistance of pancreatic cancer cells to cytotoxic agents (3) .
The reasons for the aggressiveness of this disorder are not known. However, cultured human pancreatic carcinoma cells have an overabundance of epidermal growth factor (EGF)' receptors, express transforming growth factor-alpha (TGF-a), and avidly internalize and recycle EGF (4) (5) (6) . Overexpression ofthe EGF receptor, a transmembrane protein which possesses intrinsic tyrosine kinase activity, is associated with the malignant phenotype (7) (8) and with enhanced ability of certain tumors to invade normal tissues and to metastasize (9) (10) . Overexpression of either EGF or TGF-a, both of which activate the EGF receptor, also leads to abnormal cell growth and acquisition of features that are characteristic of the transformed phenotype (11) (12) . Taken together, these observations raise the possibility that the abundance of EGF receptors and the concomitant availability ofboth EGF and TGF-a may provide human pancreatic cancer cells with a considerable growth advantage. However, the distribution of EGF and TGF-a in relation to the localization of the EGF receptor in normal and cancerous pancreatic tissues, and their exact site of synthesis within the human pancreas have not been investigated.
We now report that the EGF receptor, EGF, and TGF-a are expressed in the normal human pancreas, that these proteins and their respective mRNAs colocalize in the acinar cells and duct cells, and that all three proteins are overexpressed in pancreatic tumors by comparison with normal human pancreatic tissues. Tris (pH 7.5), 500 mM NaCl, and 0.05% vol/vol Tween-20, incubated for 2 h with goat anti-mouse IgG ( 1:2,500 dilution), and for 2 h with 1251-protein A (0.33 MCi/ml). After extensive washing with the Tweenbased buffer, the blots were exposed for 48-72 h at -800C to XAR-5 film (Kodak), using intensifying screens. The intensity of the radiographic bands was quantitated by laser densitometry. Northern blot analysis. Total RNA was extracted by the guanidine isothiocyanate method, fractionated on 0.8% agarose/2.2 M formaldehyde gel, stained with ethidium bromide for verification ofRNA integrity and loading equivalency, blot-transferred onto Nytran membranes (Schleicher & Schuell, Keene, NH), and cross-linked by ultraviolet irradiation (18) . The blots were then prehybridized, hybridized, and washed under two high stringency conditions, depending on whether antisense riboprobes or cDNA probes were used, as previously described (18) (19) (20) . In the case of antisense riboprobes, the blots were prehybridized for 4 h at 650C in 50% formamide, 0.5% SDS, 5x standard saline citrate (SSC) ( 1 X SSC = 150 mM NaCl, 15 mM Na citrate, pH 7.0), 5 X Denhardt's (1 X Denhardt's = 0.02% Ficoll, 0.02% polyvinylpyrrolidone, and 0.02% BSA), 250 Ag/ml salmon sperm DNA, and 50 mM Na2PO4, pH 6.5 (18) . The blots were then hybridized for 16 h at 650C in the presence of 5 X I05 cpm/ml of the labeled probe, washed at 650C in a solution containing lx sodium chloride sodium phosphate EDTA buffer (SSPE) ( 150 mM NaCl, 10 mM NaH2PO4, and 1 mM EDTA), and 0.5% SDS, and twice at 680C in a solution containing 0. lx SSPE and 0.5% SDS ( 18 ) . In the case ofcDNA probes, blots were prehybridized for 1 h at 420C in a prehybridization buffer that contained 50% formamide, 0.1% SDS, 5X SSC, 2.5x Denhardt's, 250 Mg/ml salmon sperm DNA, 50 mM Na2PO4, pH 6.5. The blots were hybridized at 420C for 16 h with the labeled cDNA probe (6 X 104 cpm/ml), washed twice at 23°C in 6X SSPE/0.5% SDS, twice at 37°C in 1X SSPE/0.5% SDS, and once at 57°C in 0.1X SSPE/0.5% SDS (18) . All blots were exposed at -80°C to Kodak XAR-5 film with Kodak intensifying screens, and the intensity ofthe radiographic bands was quantified by laser densitometry.
Methods
Two cDNA probes were used for filter hybridizations: a 0.56-kb EcoRI fragment of human EGF phEGF121 cDNA (American Type Culture Collection, Rockville, MD), and a BamHI 0.19-kb fragment of the mouse 7S ribosomal cDNA (21 ) that cross-hybridizes with human ribosomal RNA. In addition, a 0.86-kb EcoRI fragment ofhuman EGF receptor HER pA21 cDNA and a 1.3-kb EcoRI fragment of human TGF-a cDNA were subcloned into the pGem 3 plasmid vector (22) before use in filter hybridizations. cDNA probes were labeled with [a-32P]dCTP (3,000 Ci/mmol; New England Nuclear, Boston, MA) to a sp act of 0.5-1 x I09 dpm/ Mg, using random hexanucleotide primers (23) . The synthesis of antisense probes was carried out with [32P]CTP (3,000 Ci/mmol, New England Nuclear), yielding probes with a sp act of 0.8-1 X 109 cpm/Ag (24) .
In situ hybridization. Tissue sections were deparaffinized, incubated at 23°C for 10 min with 1 Ag/ml proteinase K (Boehringer Mannheim Biochemicals, Indianapolis, IN), and for 10 min with 0.5X SSC. Tissue sections were then incubated for 3 h at 42°C in hybridization solution which contained 0.3 M NaCi, 20 mM Tris, pH 8.0, 5 mM EDTA, 50% formamide, lx Denhardt's, 10% dextran sulfate, and 10 mM dithiothreitol (25) . Hybridization was initiated by the addition of fresh hybridization buffer containing 120,000 cpm of the probe and 50
Mlg of yeast tRNA (Gibco BRL, Inc., Gaithersburg, MD), and continued overnight at 50°C (25) . The sections were then washed at 23°C in 2x SSC, 10 mM fl-mercaptoethanol, and I mM EDTA for 10 min (two times each), and digested with RNAse A (20 Mug/ml; Sigma Chemical Co., St. Louis, MO) for 30 min at 23°C. The slides were then washed three times (8 min each) at 23°C, and twice at 50°C (60 min each) in 0.IX SSC, 10 mM fl-mercaptoethanol, and 1 mM EDTA (25) . The sections were then washed twice (10 min each) in 0.5X SSC at 23°C, dehydrated by immersion in graded alcohol containing 0.3 M ammonium acetate, dried, coated with NTB2 nuclear emulsion (Eastman Kodak Co.), and exposed in the dark for 5-10 d. After development the slides were counterstained with Mayer's hematoxylin.
The EGF receptor and TGF-a antisense probes described above were also used for in situ hybridization studies. In addition, a 0.56-kb EcoRI fiagment of human EGF cDNA (26) was subcloned into the pSP65 plasmid vector, and used for synthesis of EGF antisense probe. Pretreatment of the slides with RNAse abolished the hybridization signal by the three antisense probes. Furthermore, sense probes corresponding to the three antisense probes failed to produce a signal.
Video image analysis. To obtain quantitative analysis of in situ hybridization data, sections were examined with a dark-field filter usinga Nikon Diaphot microscope and Nikon FX microscopic photometric system (Tokyo, Japan) equipped with a video camera and a video image analysis system (Image I Videoimage Analysis System, West Chester, PA). Images were scanned for average pixel intensity and background density, allowing for computer-based correction of any uneven image illumination, using a Compaq computer and the Phoscan program (27) . Densitometric analysis of the silver grains was measured under a magnification of 400 in 12 randomly selected fields per slide, using four normal tissues and four cancerous tissues. The number of grains were calculated as a percentage of the area occupied by the silver grains in a total area of each field.
Statistical analysis. Whenever indicated, data were analyzed by Student's t test, using the StatView 512 computer program (Brainpower, Inc., Calabasas, CA).
Results
In normal human pancreatic tissues, EGF receptor immunoreactivity was present on the apical surface of most ductal cells and on the surface and partially in the cytoplasm of many acinar cells (Fig. 1 A) . EGF (Fig. 1 B) and TGF-a (Fig. 1, C and D) immunoreactivity was present on the surface and in the cytoplasm ofmost ductal cells and many acinar cells. However, within the acini, TGF-a immunoreactivity was most prominent at the basal aspect of the cells (Fig. 1 D) .
In cancerous human pancreatic tissues, immunoreactivity for EGF receptor was present on the apical surface ofall cancer cells with ductal structures within the invasive ductal adenocarcinomas (Fig. 2 A) . EGF (Fig. 2 C) and TGF-a (Fig. 2 E) immunoreactivity was diffusely positive on the surface and in the cytoplasm ofthese cells. Immunofluorescent staining ofthe adenocarcinomas revealed diffuse cellular distribution of EGF receptor (Fig. 2 B) , EGF (Fig. 2 D) , and TGF-a (Fig. 2 F) in all duct-shaped cancer cells, which was especially intense at the apical surfaces in the case ofthe EGF receptor and TGF-a, and in the supranuclear region in the case of EGF.
Immunoblotting with the respective antibodies also revealed a marked increase in EGF receptor, EGF, and TGF-a levels in the cancerous tissues (Fig. 3) . Densitometric analysis ofthe autoradiographs indicated that EGF receptor and TGF-a protein levels were increased in the cancerous tissues by 10.6±4.5 (P< 0.05) and 13.8±4.9 (P< 0.02), respectively, by comparison with the normal tissues (fold increase, mean±SE). In the case of EGF, the protein levels were below the level of detection in the normal human pancreas, but were readily evident in the cancerous tissues (Fig. 3) .
Northern blot analysis oftotal RNA demonstrated the presence of low levels of mRNA encoding the EGF receptor (Fig.  4) and EGF (Fig. 5) , and relatively high levels of TGF-a mRNA (Fig. 5) in the normal human pancreas. In contrast, in the ductal adenocarcinomas, there was a marked increase in all three mRNA moieties. Densitometric analysis ofthe Northern blots indicated that, by comparison with the normal pancreas, there was a 3-, 15-, and 10-fold increase in the mRNA levels encoding the EGF receptor, EGF, and TGF-a, respectively (Fig. 6) . However, there did not appear to be any correlation between the histological grade ofthe pancreatic tumors and the levels of expression of the EGF receptor, EGF, and TGF-a.
In situ hybridizations with antisense probes revealed that the mRNAs encoding the EGF receptor and EGF were ex-. i0 S: Af ; pressed at low levels in the acinar cells (Fig. 7 ) and ductal cells (Fig. 8 ) of the normal human pancreas, but that the TGF-a mRNA was expressed at high levels in both cell types (Figs. 7  and 8 ). All three mRNA moieties tended to localize at the basal portion of the acinar cells (Fig. 7) , and this basal distribution was especially prominent in the case of TGF-a (Fig. 7 E) 8). In the invasive ductal adenocarcinomas, there was a marked and diffuse increase in the levels of all three RNA species by comparison with the normal pancreas (Fig. 7 , Table  I ). EGF receptor mRNA signal was also consistently detected in the endothelial cells ofblood vessels in both the normal and cancerous (Fig. 7) pancreas.
Discussion
The EGF receptor is an important protein whose activation initiates a cascade of biological processes in numerous cell types (28) . Previous studies have suggested that the EGF receptor may participate in the regulation of pancreatic exocrine function. Thus, the pancreatic acinar cell has specific, high affinity EGF receptors (29) , and EGF is present in the pancreatic juice in humans (30) . EGF potentiates secretagogue-activated digestive enzyme release in cultured mouse pancreatic acini (31 ) , prevents caerulein-induced desensitization of acinar cell secretory responsiveness when injected subcutaneously in rats (32) , interacts with both stimulatory (Gs) and inhibitory (Gi) GTP binding proteins (33) , and alters cholecystokinin-induced activation of chloride conductance in the pancreatic acinar cell (34) . EGF also enhances the survival of rat pancreatic acinar cells in serum-free culture (35) , and either inhibits ( 1 nM) or enhances( 10 nM) the proliferation of mouse pancreatic acini grown on a collagen gel (36, 37) . In vivo, EGF decreases thymidine incorporation into pancreatic DNA in male Sprague-Dawley rats (32) , but enhances thymidine incorporation in male Wistar rats (38) . Taken together, these studies suggest that the EGF receptor may have an important role in maintaining acinar cell integrity and differentiated function, and that its effects on pancreatic cell proliferation may be species specific.
In the present study, we have determined that the EGF receptor and its two principal ligands, EGF and TGF-a, are found in both the acinar cells and ductal cells of the normal human pancreas. EGF receptor immunoreactivity is especially prominent at the apical surfaces of the ductal cells, raising the possibility that at this site the receptor may function to bind and internalize intraluminal EGF and TGF-a. This may partially explain the greater abundance of both growth factors in the duct cells by comparison with the acinar cells. However, all three proteins colocalize with their respective mRNAs, and the in situ hybridization data suggest that the mRNAs for both ligands are expressed to a greater extent in ductal cells than in acinar cells. Similarly, the abundance of TGF-a in the basal aspect of the acinar cells correlates with the increased expression of TGF-a at this site. Taken together, these observations suggest that all three proteins are synthesized in both acinar cells and duct cells.
The reasons for the coexpression in the normal pancreas of two growth factors that bind and activate the same receptor are not readily evident. It is possible that the two factors may regulate different biological functions in these cells. In support of this hypothesis, in T3M4 human pancreatic cancer cells, EGF and TGF-a exert differential effects on EGF receptor downregulation and tyrosine phosphorylation, and exhibit quantitative and qualitative differences with respect to the generation of biologically active inositol tris phosphate (39 findings indicate that the EGF receptor, EGF, and TGF-a are all expressed at higher levels in human pancreatic cancer by comparison with the normal human pancreas, and that this overexpression is especially marked in the ductal-shaped cells of the invasive adenocarcinoma. In these cells, EGF receptor and TGF-a immunoreactivity is found on both the cell surface and in the cytoplasm, and is especially prominent at the apical surfaces. In contrast, EGF exhibits a diffuse cytoplasmic pattern with increased immunostaining in the supranuclear region of the cells. The increased immunostaining is associated with elevated protein levels by immunoblotting and with an increase in the respective mRNA levels. These observations point toward either enhanced production and/or decreased degradation of these mRNA moieties in the tumor cells. The colocalization of these mRNAs indicates that the three proteins are synthesized within the same cells, thereby supporting the concept of a functional EGF receptor autocrine cycle in human pancreatic cancer cells. With respect to TGF-a, this hypothesis is strengthened by the known ability of the membrane-bound TGF-a precursor to activate the EGF receptor (42) , and by the abundance of EGF receptors and TGF-a at the apical surfaces of duct cells. It is widely recognized that perturbations in the functions of growth factors and their receptors and/or their aberrant expression may lead to abnormal cell growth, acquisition of features that are characteristic of the transformed phenotype, and progression to neoplasia with unrestrained growth and ability to invade normal tissues and metastasize (43) . Increased EGF receptor number is associated with enhanced metastatic potential in human breast cancer ( 13) and enhanced tumor invasiveness in human bladder cancer (14) . Furthermore, the EGF receptor is overexpressed in several different types ofmalignancies in humans, including glial, pulmonary, breast, gastric, squamous, and colonic carcinomas (9) . A variety of cancers also exhibit enhanced expression of TGF-a (44) . Recently, a number of human gastric carcinomas were shown to express high mRNA levels encoding the EGF receptor, EGF, and TGF-a (45) . However, to our knowledge, our findings are the first to document by in situ hybridization that a given malignancy can be associated with overexpression ofthe EGF receptor, EGF, and TGF-a by the same cells within the tumor mass.
Three lines of evidence suggest that TGF-a may have an especially important role in the pathophysiology of pancreatic neoplasms. TGF-a is more potent than EGF at stimulating the these observations raise the possibility that, within the ductular microenvironment of the exocrine pancreas, the alkaline pH and the abundance of EGF, TGF- Figure 8 . In situ hybridization analyzed by light-field microscopy. Expression pattern of mRNAs encoding EGF receptor (A), EGF (B), and TGF-a (C) in the normal human pancreas, as detected with antisense probes. The mRNAs encoding EGF receptor, EGF, and TGFa are found at high levels at the apical portion of the pancreatic ductal cells (arrows). Magnification, 200. anchorage-independent growth of cultured human pancreatic cancer cells (9) . TGF-a binding, but not EGF binding, is increased at pH 8.2 (39) , which is the pH of human pancreatic juice. The exocrine pancreas is one of the principal target organs that is damaged in transgenes that overexpress TGF-a (46, 47) . These transgenes exhibit an increase in pancreatic acinar cell and fibroblastic proliferation, in association with extensive pseudoductular metaplasia (46, 47) . Taken together,
